世界の帯状疱疹ワクチン市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20DC9730)
◆商品コード:GIR20DC9730
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年12月(※2024年版があります。お問い合わせください。)
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、帯状疱疹ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。帯状疱疹ワクチンの種類別市場規模(生、組換え)、用途別市場規模(政府機関、民間部門、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):GSK、Merck、Sanofi Pasteur、
・地域別グローバル市場分析 2015年-2020年
・帯状疱疹ワクチンの北米市場(アメリカ、カナダ、メキシコ)
・帯状疱疹ワクチンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・帯状疱疹ワクチンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・帯状疱疹ワクチンの南米市場(ブラジル、アルゼンチン)
・帯状疱疹ワクチンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:生、組換え
・用途別分析:政府機関、民間部門、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Zoster Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Zoster Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Zoster Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Zoster Vaccine market has been segmented into
Live
Recombinant

By Application, Zoster Vaccine has been segmented into:
Government Institution
Private Sector
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Zoster Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Zoster Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Zoster Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Zoster Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Zoster Vaccine Market Share Analysis
Zoster Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Zoster Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Zoster Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Zoster Vaccine are:
GSK
Merck
Sanofi Pasteur

Among other players domestic and global, Zoster Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Zoster Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Zoster Vaccine, with price, sales, revenue and global market share of Zoster Vaccine in 2018 and 2019.
Chapter 3, the Zoster Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Zoster Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Zoster Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Zoster Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Zoster Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Zoster Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Live
1.2.3 Recombinant
1.3 Market Analysis by Application
1.3.1 Overview: Global Zoster Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Overview of Global Zoster Vaccine Market
1.4.1 Global Zoster Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Zoster Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Zoster Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi Pasteur
2.3.1 Sanofi Pasteur Details
2.3.2 Sanofi Pasteur Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi Pasteur SWOT Analysis
2.3.4 Sanofi Pasteur Product and Services
2.3.5 Sanofi Pasteur Zoster Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Zoster Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Zoster Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Zoster Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Zoster Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Zoster Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Zoster Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Zoster Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Zoster Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Zoster Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Zoster Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Zoster Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Zoster Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Zoster Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Zoster Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Zoster Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Zoster Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Zoster Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Zoster Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Zoster Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Zoster Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Zoster Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Zoster Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Zoster Vaccine Sales and Growth Rate (2015-2020)
6.4 France Zoster Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Zoster Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Zoster Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Zoster Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Zoster Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Zoster Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Zoster Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Zoster Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Zoster Vaccine Sales and Growth Rate (2015-2020)
7.5 India Zoster Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Zoster Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Zoster Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Zoster Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Zoster Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Zoster Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Zoster Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Zoster Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Zoster Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Zoster Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Zoster Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Zoster Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Zoster Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Zoster Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Zoster Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Zoster Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Zoster Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Zoster Vaccine Price by Type (2015-2020)
11 Global Zoster Vaccine Market Segment by Application
11.1 Global Zoster Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Zoster Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Zoster Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Zoster Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Zoster Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Zoster Vaccine Market Forecast (2021-2025)
12.2.2 Europe Zoster Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Zoster Vaccine Market Forecast (2021-2025)
12.2.4 South America Zoster Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Zoster Vaccine Market Forecast (2021-2025)
12.3 Zoster Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Zoster Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Zoster Vaccine Market Share Forecast by Type (2021-2025)
12.4 Zoster Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Zoster Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Zoster Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【掲載企業】

GSK、Merck、Sanofi Pasteur、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の帯状疱疹ワクチン市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)]についてメールでお問い合わせはこちらでお願いします。